Benítez-Arvizu G, Palma-Lara I, Alcántara-Quintana LE

Language: Spanish
References: 17
Page: 244-247
PDF size: 46.20 Kb.

ABSTRACT

The storage and acquisition of human tissue samples have always been present in medicine for centuries; however, biobanks activity has only recently appeared as such. The aim of this review is to give a global perspective of the positioning of biobanks, particularly an overview of what happens in Mexico. One of the main challenges of our country is to establish concerted actions, in wich biobank networks will be developed and have the opportunity to share and create new science, and to build bridges to facilitate improved practices and standardization of biobanks

REFERENCES

1. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J. 2007;30(2):373-82.

2. Kauffmann F, Cambon-Thomsen A. Tracing biological collections: between books and clinical trials. JAMA. 2008;299(19):2316-8.

3. Gottweis H, Zatloukal K. Biobank governance: Trends and perspectives. Pathobiology. 2007;74(4):206-11.

4. Yuille M, van Ommen GJ, Bréchot C, Cambon- Thomsen A, Dagher G, et al. Biobanking for Europe. Brief Bioinform. 2008;9(1):14-24.

5. Bevilacqua G, Bosman F, Dassesse T, Höfl er H, Janin A, Langer R, et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch. 2010;456(4):449-54.

6. Hainaut P, Caboux E, Bevilacqua G, Bosman F, Dassesse T, Hoefl er H, et al. Pathology as the cornerstone of human tissue banking: European Consensus Expert Group Report. Biopreserv Biobank. 2009;7(3):157-60.

7. Riegman PHJ, Morente MM, Betsou F, de Blasio P, Geary P; Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare. Mol Oncol. 2008;2(3):213-22.

8. Hewitt RE. Biobanking: The foundation of personalized medicine. Curr Opin Oncol. 2011;23(1):112-9.

9. Bell WC, Sexton KC, Grizzle WE. Organizational issues in providing high quality human tissues and clinical information for the support of biomedical research. Methods Mol Biol. 2010;576:1-30.

10. Cronin AJ, Douglas JF. Non-standard kidneys for transplants: Clinical margins, medical morality, and the law. Med Law Rev. 2013;21(3):448-73.

11. Vellón L, Martin AG. Stem cell biobanks for research. Dilemata. 2011;3(7):1-16. Disponible en http://www.dilemata.net/revista/index.php/dilemata/ article/view/103/105

12. Vaught JB, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010;19(4):912-5.

13. Guerin JS, Murray DW, McGrath MM. Molecular medicine Ireland guidelines for standardized biobanking. Biopreserv Biobank. 2010;8(1):3-63.

14. Wichmann E. Need for guidelines for standardized biobanking. Biopreserv Biobank. 2010;8(1):1.

15. Betsou F, Luzergues A, Carter A, Geary P, Riegman P, Clarck B, et al. Towards norms for accreditation of biobanks for human health and medical research: Compilation of existing guidelines into an ISO certifi cation/accreditation norm-compatible format. Qual Assurance J. 2007;11:221-94.

16. Khleif SN, Doroshow JH, Hait WN; AACR-FDANCI Cancer Biomarkers Collaborative. AACRFDA- NCI Cancer Biomarkers. Collaborative consensus report: Advancing the use of biomarkers in cancer drug development. Clin Cancer Res. 2010;16(13):3299-318.

17. Vaught J, Baust JG, Heacox AE, Riegman P, Betsou F, Mazur P, et al. What are three actionable strategies to improve quality in biomedical research? Biopreserv Biobank. 2010;8(3):121-5.